Impact of MRI in the management and staging of cancer of the uterine cervix

Acta Oncologica

Volumn 50, Issue 3, 2011, Pages 420-426

  Stenstedt, Kristina ^a   Hellström, Ann Cathrin ^a   Fridsten, Susanne ^a   Blomqvist, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GADOLINIUM CHELATE;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ADVANCED CANCER; APPENDIX CANCER; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CARCINOMA; CHEMORADIOTHERAPY; CLEAR CELL CARCINOMA; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GLASSY CELL CARCINOMA; GYNECOLOGIC SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LUNG EMBOLISM; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RECURRENT CANCER; RETROSPECTIVE STUDY; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA; UTERUS PERFORATION; VAGINAL TRACHELECTOMY;

ADULT; AGED; ALGORITHMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 79952666077     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.541932     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
2. Bergström R, Sparé n P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 1999;81:159-66.
3. Cancer Incidence in Sweden 2007. Health and Diseases. The National Board of Health and Welfare; Stockhalm. 2008; p. 11.
4. Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecological cancers. FIGO committee on gynecologic oncology. Int J Gynecol Obst 2000 Aug;70(2):209-62.
5. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of diseasefree interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-7. (Pubitemid 20362555)
6. Pedullà F, Centurioni MG, Foglia G, Ferrari I, Orsatti M, Vitale V, et al. Treatment of FIGO stage Ib cervical carcinoma with nodal involvement. Eur J Gynaecol Oncol 1994;15:59-64.
7. Tinga DJ, Timmer PR, Bouma J, Aalders JG. Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol 1990;39: 175-80. (Pubitemid 20372408)
8. Chung HH, Kang SB, Cho JY, Kim JW, Park NH, Song YS, et al. Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer? Jpn J Clin Oncol 2007;37:370-5. (Pubitemid 47248956)
9. Choi SH, Kim SH, Choi HJ, Park BK, Lee HJ. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: Results of a prospective study. J Comput Assist Tomogr 2004;28:620-7. (Pubitemid 39195536)
10. Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J. Computed tomography and magnetic resonance imaging of uterine cervical carcinoma: A systematic review. Gynecol Oncol 2003;91:59-66. (Pubitemid 37188594)
11. Vidaurreta J, Berm ú dez A, di Paola G, Sardi J. Laparoscopic staging in locally advanced cervical carcinoma: A new possible philosophy? Gynecol Oncol 1999;75:366-71.
12. Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: Experience of the Gynecology Oncology Group. Gynecol Oncol 1980;9:90-8. (Pubitemid 10175950)
13. LaPolla JP, Schlaerth JB, Gaddis O, Morrow CP. The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecol Oncol 1986; 24:194-206. (Pubitemid 16060022)
14. Mitchell DG, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola M, et al. Early invasive cervical cancer: Tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol 2006;24:5687-94. (Pubitemid 46631310)
15. Van Nagell JR Jr, Roddick JW Jr, Lowin DM. The staging of cervical cancer: Inevitable discrepancies between clinical staging and pathologic findings. Am J Obstet Gynecol 1971;110:973-8.
16. Hricak H, Lacey CG, Sandles LG. Invasive cervical carcinoma: Comparison of MR imaging and surgical findings. Radiology 1988;166:623-31. (Pubitemid 18058914)
17. Subak LL, Hricak H, Powell CB. Cervical carcinoma: Computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995;86:43-50.
18. Höc kel M. Ultra-radical compartmentalized surgery in gynaecological oncology. Eur J Surg Oncol 2006;32:859-65.
19. Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: Results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 2005;23:9329-37.
20. Amendola MA, Hricak H, Mitchell DG, Snyder B, Chi DS, Long HJ III, et al. Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: Results of Intergroup Protocol ACRIN 6651/GOG 183. J Clin Oncol 2005;23:7454-9. (Pubitemid 46291807)
21. Narayan K. Arguments for a magnetic resonance imagingassisted FIGO staging system for cervical cancer. Int J Gynecol Cancer 2005;15:573-82. (Pubitemid 41022893)
22. Whitney CW, Stehman FB. The abandoned radical hysterectomy: A Gynecologic Oncology Group Study. Gynecol Oncol 2000;79:350-6.